Jan 23 (Reuters) - CANTARGIA AB:
* CANTARGIAâ€˜S EUROPEAN PATENT FOR HAEMATOLOGICAL CANCERS REMAINS IN FORCE Source text for Eikon: Further company coverage: (Gdynia Newsroom)
 